Gege Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gege Feng has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Jianwei Liu
Department of Gastroenterology, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China
3 shared publicationsJun Peng
Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China, qiluhospital.com
3 shared publicationsShaoqiu Leng
Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
3 shared publicationsQi Feng
Department of Hematology Qilu Hospital of Shandong University Jinan China
2 shared publicationsQiang Liu
Department of Hematology Qilu Hospital of Shandong University Jinan China
2 shared publicationsXiaoyu Zhang
Department of Hematology Qilu Hospital of Shandong University Jinan China
2 shared publications
Latest Publications
- 12 February 2026
- Published by Elsevier in Experimental Hematology
- Vol. 157, 105400
Identification of key biomarkers for initial corticosteroid resistance in newly diagnosed primary immune thrombocytopenia
- 12 February 2026
- Published by Elsevier in Experimental Hematology
- Vol. 157, 105400
Identification of key biomarkers for initial corticosteroid resistance in newly diagnosed primary immune thrombocytopenia
- Open Access
- 2 January 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Helicobacter pylori infection is causally associated with extra-gastric tumors: a Mendelian randomization study
Background Helicobacter pylori (H. pylori) infection is a major pathogen associated with gastric cancer. However, the causal relationship between H. pylori infection and extra-gastric tumors has not been fully elucidated. Methods A two-sample Mendelian randomization (MR) study was conducted using genome-wide association study (GWAS) data on serum H. pylori IgG levels as the exposure variable and GWAS data on 268 benign and malignant tumors as the outcome variable. Single nucleotide polymorphisms (SNPs) associated with the exposure were identified from the OpenGWAS and GWAS Catalog databases, while those linked to the outcome were sourced from the FinnGen database. Independent MR analyses were performed on the discovery and validation cohorts. Sensitivity analyses, including heterogeneity and pleiotropy assessments, were conducted to ensure the robustness of the results. Meta-analysis was used to integrate significant findings from both cohorts. Results Our findings demonstrated negative causal effects of H. pylori infection on benign neoplasms of cranial nerves and extrahepatic bile ducts in both discovery and validation cohorts. Moreover, we found a potentially positive causal link between H. pylori infection and certain malignancies of the hypopharynx, kidney, lip, brain, pancreas, and neuroendocrine system, as well as malignant immunoproliferative diseases and leukemia, although these results were only observed in a single cohort. Sensitivity analyses showed no significant heterogeneity or horizontal pleiotropy in the significant MR directions, supporting the reliability of the results. Meta-analysis further confirmed the protective effect of H. pylori infection on benign cranial nerve and extrahepatic bile duct tumors. Conclusion This study revealed that H. pylori infection is causally associated with extra-gastric tumors, suggesting a potential protective role of H. pylori infection in certain benign tumors.
- 2 January 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Open AccessHelicobacter pylori infection is causally associated with extra-gastric tumors: a Mendelian randomization study
Background Helicobacter pylori (H. pylori) infection is a major pathogen associated with gastric cancer. However, the causal relationship between H. pylori infection and extra-gastric tumors has not been fully elucidated. Methods A two-sample Mendelian randomization (MR) study was conducted using genome-wide association study (GWAS) data on serum H. pylori IgG levels as the exposure variable and GWAS data on 268 benign and malignant tumors as the outcome variable. Single nucleotide polymorphisms (SNPs) associated with the exposure were identified from the OpenGWAS and GWAS Catalog databases, while those linked to the outcome were sourced from the FinnGen database. Independent MR analyses were performed on the discovery and validation cohorts. Sensitivity analyses, including heterogeneity and pleiotropy assessments, were conducted to ensure the robustness of the results. Meta-analysis was used to integrate significant findings from both cohorts. Results Our findings demonstrated negative causal effects of H. pylori infection on benign neoplasms of cranial nerves and extrahepatic bile ducts in both discovery and validation cohorts. Moreover, we found a potentially positive causal link between H. pylori infection and certain malignancies of the hypopharynx, kidney, lip, brain, pancreas, and neuroendocrine system, as well as malignant immunoproliferative diseases and leukemia, although these results were only observed in a single cohort. Sensitivity analyses showed no significant heterogeneity or horizontal pleiotropy in the significant MR directions, supporting the reliability of the results. Meta-analysis further confirmed the protective effect of H. pylori infection on benign cranial nerve and extrahepatic bile duct tumors. Conclusion This study revealed that H. pylori infection is causally associated with extra-gastric tumors, suggesting a potential protective role of H. pylori infection in certain benign tumors.
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
Observational and Genetic Association of Myelodysplastic Syndromes (MDS) and Autoimmune Diseases in Adults
About 25% of patients with myelodysplastic syndromes (MDS) have combined autoimmune diseases (AIDs). However, the relationships between MDS and AIDs, especially a causal relationship and the underlying shared pathophysiological mechanisms, remain largely unknown. We aimed to evaluate the association between MDS and AIDs using a multicenter retrospective study, Mendelian randomization (MR), and bioinformatics analysis. About 26.6% of patients with MDS from all centers presented with AIDs. Compared to MDS patients without AIDs, MDS with AIDs was less likely to progress to acute myeloid leukemia (AML) (6.6% vs. 15.1%, p = 0.037), and the pre‐existing AIDs could be used as an independent protective factor of survival (HR: 0.504, p = 0.048). Bidirectional MR results showed that MDS could cause the risk of systemic lupus erythematosus (SLE, OR: 1.09, p = 0.015), although with no significant causal relationship in other AIDs. The effect of MDS on SLE may be partially mediated by naïve CD4+ T‐cells (median proportion 6.9%) and CD45RA‐CD4+ T memory cells (median proportion 9.0%). Furthermore, two hub genes (IFI27 and VSIG4) were identified by machine learning and curve analysis as potential diagnostic markers for MDS with SLE. Our study suggested that the impact and mechanisms of AIDs in MDS need to be taken seriously, which could provide more accurate treatment guidance.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
Open AccessObservational and Genetic Association of Myelodysplastic Syndromes (MDS) and Autoimmune Diseases in Adults
About 25% of patients with myelodysplastic syndromes (MDS) have combined autoimmune diseases (AIDs). However, the relationships between MDS and AIDs, especially a causal relationship and the underlying shared pathophysiological mechanisms, remain largely unknown. We aimed to evaluate the association between MDS and AIDs using a multicenter retrospective study, Mendelian randomization (MR), and bioinformatics analysis. About 26.6% of patients with MDS from all centers presented with AIDs. Compared to MDS patients without AIDs, MDS with AIDs was less likely to progress to acute myeloid leukemia (AML) (6.6% vs. 15.1%, p = 0.037), and the pre‐existing AIDs could be used as an independent protective factor of survival (HR: 0.504, p = 0.048). Bidirectional MR results showed that MDS could cause the risk of systemic lupus erythematosus (SLE, OR: 1.09, p = 0.015), although with no significant causal relationship in other AIDs. The effect of MDS on SLE may be partially mediated by naïve CD4+ T‐cells (median proportion 6.9%) and CD45RA‐CD4+ T memory cells (median proportion 9.0%). Furthermore, two hub genes (IFI27 and VSIG4) were identified by machine learning and curve analysis as potential diagnostic markers for MDS with SLE. Our study suggested that the impact and mechanisms of AIDs in MDS need to be taken seriously, which could provide more accurate treatment guidance.
- Open Access
- 30 October 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1443090
The causal relationship between trace element status and upper gastrointestinal ulcers: a Mendelian randomization study
Background: This study aimed to investigate the bidirectional causal relationships between trace elements (such as zinc, magnesium, phosphate, and folate) and upper gastrointestinal ulcers (including gastric and duodenal ulcers). We utilized a two-sample Mendelian randomization (MR) analysis to achieve this.Methods: We conducted a two-sample MR analysis using summary-level data from genome-wide association studies (GWAS) obtained from public genomics repositories. We utilized a range of MR methods, including inverse-variance weighted (IVW), MR-Egger, and weighted median methods, and conducted a meta-analysis to synthesize results across different datasets. To ensure the robustness of our findings, we performed extensive sensitivity analyses, including pleiotropy assessment, heterogeneity tests, and leave-one-out analysis.Results: Our findings are significant, indicating a positive causal relationship between increased zinc levels and the risk of gastric ulcers. Moreover, magnesium and folate appear to offer potential protective effects against gastroduodenal ulcers (p < 0.05). The meta-analysis further supports the causal relationship between zinc and gastric ulcers (p < 0.05), confirming zinc’s significant causal impact on this condition.Conclusion: The study confirms a positive causal relationship between zinc and gastric ulcers and highlights the complexity of how trace elements regulate the progression of upper gastrointestinal ulcers. These results provide a scientific basis for dietary recommendations regarding trace element intake in clinical and public health practices. They also offer new insights into effective prevention and treatment strategies for gastric and duodenal ulcers.
- 30 October 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1443090
Open AccessThe causal relationship between trace element status and upper gastrointestinal ulcers: a Mendelian randomization study
Background: This study aimed to investigate the bidirectional causal relationships between trace elements (such as zinc, magnesium, phosphate, and folate) and upper gastrointestinal ulcers (including gastric and duodenal ulcers). We utilized a two-sample Mendelian randomization (MR) analysis to achieve this.Methods: We conducted a two-sample MR analysis using summary-level data from genome-wide association studies (GWAS) obtained from public genomics repositories. We utilized a range of MR methods, including inverse-variance weighted (IVW), MR-Egger, and weighted median methods, and conducted a meta-analysis to synthesize results across different datasets. To ensure the robustness of our findings, we performed extensive sensitivity analyses, including pleiotropy assessment, heterogeneity tests, and leave-one-out analysis.Results: Our findings are significant, indicating a positive causal relationship between increased zinc levels and the risk of gastric ulcers. Moreover, magnesium and folate appear to offer potential protective effects against gastroduodenal ulcers (p < 0.05). The meta-analysis further supports the causal relationship between zinc and gastric ulcers (p < 0.05), confirming zinc’s significant causal impact on this condition.Conclusion: The study confirms a positive causal relationship between zinc and gastric ulcers and highlights the complexity of how trace elements regulate the progression of upper gastrointestinal ulcers. These results provide a scientific basis for dietary recommendations regarding trace element intake in clinical and public health practices. They also offer new insights into effective prevention and treatment strategies for gastric and duodenal ulcers.
- 24 July 2023
- Published by Wiley in British Journal of Haematology
- Vol. 203 (2) , 295-303
Obesity is associated with poor outcomes of corticosteroid treatment in patients with primary immune thrombocytopenia
Summary: Emerging evidence has demonstrated that obesity impacts multiple immune‐related diseases. It remains unclear whether and how obesity alters treatment outcomes in patients with primary immune thrombocytopenia (ITP). Thus, we retrospectively investigated 214 treatment‐naïve patients who received standard high‐dose dexamethasone therapy in Qilu Hospital. Patients with obesity showed significantly lower overall initial response (underweight vs. normal vs. overweight vs. obese: 85.7% vs. 85.2% vs. 72.0% vs. 52.3%, p = 0.001) and initial complete response ([CR], 71.4% vs. 70.4% vs. 53.3% vs. 27.3%, p < 0.001) rates. The same trend was observed in the 6‐month sustained response (63.6% vs. 52.3% vs. 35.6% vs. 22.7%, p = 0.03) and sustained CR (36.4% vs. 44.6% vs. 24.4% vs. 9.1%, p = 0.01). The Kaplan–Meier analysis revealed a shortened duration of remission in the obese group (median duration of remission, not reached vs. 16 months vs. 2 months vs. 1 month, p = 0.002). In multivariate regression analysis, obesity was independently associated with poor initial and sustained responses, and an increased risk for relapse. In conclusion, obesity is a negative predictor for outcomes of corticosteroid treatment. A stratified strategy according to body mass index status may facilitate the precision management of ITP.
- 24 July 2023
- Published by Wiley in British Journal of Haematology
- Vol. 203 (2) , 295-303
Obesity is associated with poor outcomes of corticosteroid treatment in patients with primary immune thrombocytopenia
Summary: Emerging evidence has demonstrated that obesity impacts multiple immune‐related diseases. It remains unclear whether and how obesity alters treatment outcomes in patients with primary immune thrombocytopenia (ITP). Thus, we retrospectively investigated 214 treatment‐naïve patients who received standard high‐dose dexamethasone therapy in Qilu Hospital. Patients with obesity showed significantly lower overall initial response (underweight vs. normal vs. overweight vs. obese: 85.7% vs. 85.2% vs. 72.0% vs. 52.3%, p = 0.001) and initial complete response ([CR], 71.4% vs. 70.4% vs. 53.3% vs. 27.3%, p < 0.001) rates. The same trend was observed in the 6‐month sustained response (63.6% vs. 52.3% vs. 35.6% vs. 22.7%, p = 0.03) and sustained CR (36.4% vs. 44.6% vs. 24.4% vs. 9.1%, p = 0.01). The Kaplan–Meier analysis revealed a shortened duration of remission in the obese group (median duration of remission, not reached vs. 16 months vs. 2 months vs. 1 month, p = 0.002). In multivariate regression analysis, obesity was independently associated with poor initial and sustained responses, and an increased risk for relapse. In conclusion, obesity is a negative predictor for outcomes of corticosteroid treatment. A stratified strategy according to body mass index status may facilitate the precision management of ITP.
- 26 December 2022
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 211 (1) , 68-77
Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID
Common variable immunodeficiency (CVID) is a ‘late-onset’ primary immunodeficiency characterized by variable manifestations and genetic heterogeneity. A monogenic cause of CVID has been reported in 10% of patients. In this study, we identified two novel pathogenic variants implicated in monogenic CVID by whole exome sequencing (WES) analysis: a heterozygous nuclear factor κB subunit 1 (NFKB1) p.G686fs mutation and a homozygous inducible T-cell co-stimulator (ICOS) p.L96Sfs mutation. The predicted crystal models indicated premature truncation of the two mutated proteins. Both variants were demonstrated as loss-of-function mutations and were associated with overlapped manifestations of respiratory fungal infection and splenomegaly. We further performed a detailed assessment of immunologic phenotypes and impaired lymphocyte functions in patients. Moreover, we discovered an association between monoclonal T-large granular lymphocyte proliferation and ICOS-deficient CVID for the first time. These observations lead to a new perspective on the underlying genetic heterogeneity of CVID.
- 26 December 2022
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 211 (1) , 68-77
Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID
Common variable immunodeficiency (CVID) is a ‘late-onset’ primary immunodeficiency characterized by variable manifestations and genetic heterogeneity. A monogenic cause of CVID has been reported in 10% of patients. In this study, we identified two novel pathogenic variants implicated in monogenic CVID by whole exome sequencing (WES) analysis: a heterozygous nuclear factor κB subunit 1 (NFKB1) p.G686fs mutation and a homozygous inducible T-cell co-stimulator (ICOS) p.L96Sfs mutation. The predicted crystal models indicated premature truncation of the two mutated proteins. Both variants were demonstrated as loss-of-function mutations and were associated with overlapped manifestations of respiratory fungal infection and splenomegaly. We further performed a detailed assessment of immunologic phenotypes and impaired lymphocyte functions in patients. Moreover, we discovered an association between monoclonal T-large granular lymphocyte proliferation and ICOS-deficient CVID for the first time. These observations lead to a new perspective on the underlying genetic heterogeneity of CVID.
- 13 November 2022
- Published by Elsevier in Gastroenterology
- Vol. 164 (6) , e13-e16
An Unusual Cause of Acute Gastroenteritis, Ascites, and Eosinophilia in a 29-Year-Old Woman
- 13 November 2022
- Published by Elsevier in Gastroenterology
- Vol. 164 (6) , e13-e16
An Unusual Cause of Acute Gastroenteritis, Ascites, and Eosinophilia in a 29-Year-Old Woman
- 17 August 2022
- Published by Elsevier in Gastroenterology
- Vol. 164 (2) , e10-e13
A 41-Year-Old Man With an Abdominal Mass and Hepatomegaly
- 17 August 2022
- Published by Elsevier in Gastroenterology
- Vol. 164 (2) , e10-e13
A 41-Year-Old Man With an Abdominal Mass and Hepatomegaly
- Open Access
- 1 December 2015
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 5 (1) , 1-8
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes
Dys-megakaryopoiesis is defined as ≥10 % of dysplastic megakaryocytes in bone marrow smears by the World Health Organization. However, concordance rates for dysplastic megakaryocytes between different observers is low and, consequently, evaluation of dysmegakaryopoiesis is also often discordant. We performed CD41 immune staining and proposed a systematic classification of dys-megakaryopoiesis on bone marrow films: (1) micro-megakaryocytes (<12 µm); (2) micro-megakaryocytes (12–40 µm) with 1 nucleus; (3) micro-megakaryocytes (12–40 µm) with 2 nuclei; (4) micro-megakaryocytes (12–40 um) with multiple (more than 2) nuclei; (5) dysplastic megakaryocytes (≥40 µm) with 1 nucleus; (6) dysplastic megakaryocytes (≥40 µm) with 2 nuclei; and (7) dysplastic megakaryocytes (≥40 µm) with multiple (more than 2) nuclei. Further, we evaluated the prognostic impact of micro-megakaryocytes and dysplastic mono-nucleated megakaryocytes on MDS patients. The best discriminator cut-off point for each group was determined by the minimal P value approach. In multivariate analyses micro-megakaryocytes ≥25 % and dysplastic mono-nucleated megakaryocytes ≥30 % were independent adverse prognostic factors (hazard ratio [HR] = 1.58 [95 % confidence interval [CI], 1.11, 2.23]; P = 0.010 and 1.53 [1.09, 2.16]; P = 0.014). Our data suggest integration of micro-megakaryocytes and dysplastic mono-nucleated megakaryocytes improve predictive accuracy of the international prognostic scoring system-revised (IPSS-R) scoring system.
- 1 December 2015
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 5 (1) , 1-8
Open AccessA systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes
Dys-megakaryopoiesis is defined as ≥10 % of dysplastic megakaryocytes in bone marrow smears by the World Health Organization. However, concordance rates for dysplastic megakaryocytes between different observers is low and, consequently, evaluation of dysmegakaryopoiesis is also often discordant. We performed CD41 immune staining and proposed a systematic classification of dys-megakaryopoiesis on bone marrow films: (1) micro-megakaryocytes (<12 µm); (2) micro-megakaryocytes (12–40 µm) with 1 nucleus; (3) micro-megakaryocytes (12–40 µm) with 2 nuclei; (4) micro-megakaryocytes (12–40 um) with multiple (more than 2) nuclei; (5) dysplastic megakaryocytes (≥40 µm) with 1 nucleus; (6) dysplastic megakaryocytes (≥40 µm) with 2 nuclei; and (7) dysplastic megakaryocytes (≥40 µm) with multiple (more than 2) nuclei. Further, we evaluated the prognostic impact of micro-megakaryocytes and dysplastic mono-nucleated megakaryocytes on MDS patients. The best discriminator cut-off point for each group was determined by the minimal P value approach. In multivariate analyses micro-megakaryocytes ≥25 % and dysplastic mono-nucleated megakaryocytes ≥30 % were independent adverse prognostic factors (hazard ratio [HR] = 1.58 [95 % confidence interval [CI], 1.11, 2.23]; P = 0.010 and 1.53 [1.09, 2.16]; P = 0.014). Our data suggest integration of micro-megakaryocytes and dysplastic mono-nucleated megakaryocytes improve predictive accuracy of the international prognostic scoring system-revised (IPSS-R) scoring system.